Literature DB >> 8202231

Recurrent migraine: cost-effective care.

A M Rapoport1.   

Abstract

The cost of untreated or ineffectively treated migraine is staggering. A case study is presented that demonstrates the importance of developing an individually tailored home treatment program for migraine patients aimed at keeping them out of healthcare facilities on an acute basis. Treatment programs should include preventive medications if attacks occur more than twice per month, as well as appropriate abortive and symptomatic agents in the event of a severe, acute migraine attack. New agents and treatment modalities are making acute treatment more cost-effective and making it less likely that unnecessary time be spent seeking medical help at the time of an attack.

Entities:  

Mesh:

Year:  1994        PMID: 8202231

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Migraine prophylactic management in neurology and primary care (2006-2015).

Authors:  Jeffrey L Jackson; Cynthia Kay; Cecilia Scholcoff; Sarah Nickoloff; Kathlyn Fletcher
Journal:  J Neurol       Date:  2018-09-19       Impact factor: 4.849

2.  Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis.

Authors:  K Payne; C M Kozma; B J Lawrence
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 3.  Tricyclic antidepressants and headaches: systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; William Shimeall; Laura Sessums; Kent J Dezee; Dorothy Becher; Margretta Diemer; Elizabeth Berbano; Patrick G O'Malley
Journal:  BMJ       Date:  2010-10-20

4.  A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Authors:  Jeffrey L Jackson; Elizabeth Cogbill; Rafael Santana-Davila; Christina Eldredge; William Collier; Andrew Gradall; Neha Sehgal; Jessica Kuester
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

5.  Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; Akira Kuriyama; Yachiyo Kuwatsuka; Sarah Nickoloff; Derek Storch; Wilkins Jackson; Zhi-Jiang Zhang; Yasuaki Hayashino
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.